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Page 1215, Sect. 4.3.1, line 5: the reference to electronic
supplementary Fig. 1, previously shown as [48] should
read [41].
Page 1218, Sect. 4.3.2, line 7: reference [48] should
appear after the text ‘‘electronic supplementary Fig. 2’’.
Supplementary Figure 1: The final sentence of the figure
legend, which previously read:
‘‘Reproduced with permission from Ruff et al. 2000 [40]’’.
Should read:
‘‘Reproduced with permission from Ruff et al. 2010 [41]’’.
Supplementary Figure 2: The final sentence of the figure
legend, which previously read:
‘‘Reproduced with permission from Raskob et al. 2013
[93]’’.
Should read:
‘‘Reproduced with permission from Raskob et al. 2013
[48]’’.
The online version of the original article can be found under
doi:10.1007/s40265-014-0261-1.
H. Bounameaux
Department of Internal Medicine, University Hospital of
Geneva, Geneva, Switzerland
H. Bounameaux (&)
Faculty of Medicine, Dean’s Office, University Medical Center
(CMU), Rue Michel Servet, 1, 1211 Geneva 4, Switzerland
e-mail: henri.bounameaux@unige.ch
A. J. Camm
Division of Clinical Sciences, St George’s University of London,
London, UK
Drugs (2014) 74:1455
DOI 10.1007/s40265-014-0280-y
